NCT07894133
Gait Parameters in Breast Cancer Receiving Chemotherapy Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Walking Speed (Meter per second)
Timeframe: One time assessment throughout the study completion an average of 3 months.
Step cycle (cycle per second)
Timeframe: One time assessment throughout the study completion an average of 3 months.
Step length (Meter)
Timeframe: One time assessment throughout the study completion an average of 3 months.
Time on each foot (Seconds)
Timeframe: One time assessment throughout the study completion an average of 3 months.
Arms and interventions
Experimental Group
360 female patients aged from 40 to 50 years, suffering from breast cancer and receiving chemotherapy
Other: Gait parameter assessment
Sites
1 site in 1 country
- National Cancer InstituteCairo, Cairo Governorate, Egypt